Efficacy of Tuberculosis Treatment in Patients with Drug-Resistant Tuberculosis with the Use of Bedaquiline: The Experience of the Russian Federation.

Anna A StarshinovaIrina DovgalykEkaterina BelyaevaAnzhela GlushkovaNikolay OsipovDmitry Anatolievich Kudlay

Published in: Antibiotics (Basel, Switzerland) (2022)

Use of bedaquiline in treatment makes it possible to achieve recovery of patients with MDR/XDR TB in 82.0% of cases with patients dropping out of treatment in 9.8%. At the same time, in patients with MDR TB, recovery was achieved in 89.9% of cases, while in patients with XDR TB, 71.9% of cases recovered.

Keyphrases

drug resistant
multidrug resistant
mycobacterium tuberculosis
acinetobacter baumannii
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
pseudomonas aeruginosa
cystic fibrosis
replacement therapy
adverse drug
drug induced